Tagraxofusp-erzs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tagraxofusp-erzs, covering 2025-05-06 to 2025-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML [Phase 1]